These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37276599)

  • 121. [Use of pharmacogenetic testing to prevent adverse drug reactions during statin therapy].
    Rumyantsev NA; Kukes VG; Kazakov RE; Rumyantsev AA; Sychev DA
    Ter Arkh; 2017; 89(1):82-87. PubMed ID: 28252633
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Can pharmacogenetics help rescue drugs withdrawn from the market?
    Shah RR
    Pharmacogenomics; 2006 Sep; 7(6):889-908. PubMed ID: 16981848
    [TBL] [Abstract][Full Text] [Related]  

  • 123. Pharmacogenomics: Prescribing Precisely.
    Wake DT; Ilbawi N; Dunnenberger HM; Hulick PJ
    Med Clin North Am; 2019 Nov; 103(6):977-990. PubMed ID: 31582008
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Pharmacogenetics of Adverse Drug Reactions.
    Osanlou O; Pirmohamed M; Daly AK
    Adv Pharmacol; 2018; 83():155-190. PubMed ID: 29801574
    [TBL] [Abstract][Full Text] [Related]  

  • 125. [Pharmacogenetics and prediction of side effects of drugs].
    Harrak M; Khabbal Y; Amarti A; El Hassouni M; Ouldim K
    Ann Biol Clin (Paris); 2014; 72(4):405-12. PubMed ID: 25119798
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Challenges in pharmacotherapy for older adults: a framework for pharmacogenomics implementation.
    Roman YM; Dixon DL; Salgado TM; Price ET; Zimmerman KM; Sargent L; Slattum PW
    Pharmacogenomics; 2020 Jun; 21(9):627-635. PubMed ID: 32425117
    [TBL] [Abstract][Full Text] [Related]  

  • 127. [Pharmacogenetics: relevant aspects for the practicing veterinarian].
    Jud Schefer R; Paine Kuhn C; Demuth D
    Schweiz Arch Tierheilkd; 2012 Dec; 154(12):521-7. PubMed ID: 23188764
    [TBL] [Abstract][Full Text] [Related]  

  • 128. Pharmacogenomics arrives.
    Petsko GA
    Genome Biol; 2004; 5(6):108. PubMed ID: 15186481
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Genetic predisposition to adverse drug reactions in the intensive care unit.
    Empey PE
    Crit Care Med; 2010 Jun; 38(6 Suppl):S106-16. PubMed ID: 20502164
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Pharmacogenomics of adverse drug reactions: practical applications and perspectives.
    Becquemont L
    Pharmacogenomics; 2009 Jun; 10(6):961-9. PubMed ID: 19530963
    [TBL] [Abstract][Full Text] [Related]  

  • 131. Genomic Variation and Pharmacokinetics in Old Age: A Quantitative Review of Age- vs. Genotype-Related Differences.
    Dücker CM; Brockmöller J
    Clin Pharmacol Ther; 2019 Mar; 105(3):625-640. PubMed ID: 29498032
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Pharmacogenetics of membrane transporters: a review of current approaches.
    Sissung TM; Goey AK; Ley AM; Strope JD; Figg WD
    Methods Mol Biol; 2014; 1175():91-120. PubMed ID: 25150868
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Germline genetic testing to predict drug response and toxicity in oncology--reality or fiction?
    Soh TI; Yong WP
    Ann Acad Med Singap; 2011 Aug; 40(8):350-5. PubMed ID: 22065000
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Drug-induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies.
    Lanvers-Kaminsky C; Zehnhoff-Dinnesen AA; Parfitt R; Ciarimboli G
    Clin Pharmacol Ther; 2017 Apr; 101(4):491-500. PubMed ID: 28002638
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Clinical Utility and Economic Impact of CYP2D6 Genotyping.
    Reynolds KK; McNally BA; Linder MW
    Clin Lab Med; 2016 Sep; 36(3):525-42. PubMed ID: 27514466
    [TBL] [Abstract][Full Text] [Related]  

  • 136. [Ethics on genetic research (1). Pharmacogenetic studies].
    Ayuso C; Abad-Santos F; Dal-Ré R; Gracia D
    Med Clin (Barc); 2011 May; 136(15):678-82. PubMed ID: 20044101
    [No Abstract]   [Full Text] [Related]  

  • 137. The role of pharmacogenomics in adverse drug reactions.
    Cacabelos R; Cacabelos N; Carril JC
    Expert Rev Clin Pharmacol; 2019 May; 12(5):407-442. PubMed ID: 30916581
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Prevention of adverse drug effects: a pharmacogenomic approach.
    Scott EN; Hasbullah JS; Carleton BC; Ross CJD
    Curr Opin Pediatr; 2020 Oct; 32(5):646-653. PubMed ID: 32796162
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Gene-drug pairings for antidepressants and antipsychotics: level of evidence and clinical application.
    Murphy LE; Fonseka TM; Bousman CA; Müller DJ
    Mol Psychiatry; 2022 Jan; 27(1):593-605. PubMed ID: 34754108
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Cardiovascular Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics for the Clinical Practitioner.
    Sleder AT; Kalus J; Lanfear DE
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):20-6. PubMed ID: 26054891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.